Literature DB >> 11721779

Intestinal perforation associated with octreotide therapy in scleroderma.

A Malcolm, K Ellard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11721779     DOI： 10.1111/j.1572-0241.2001.05286.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Utility of Octreotide in Advancing Enteral Feeds in Children with Chronic Intestinal Pseudo-Obstruction.

Authors:  Lusine Ambartsumyan; Alejandro Flores; Samuel Nurko; Leonel Rodriguez
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

2.  A Case of Dermatomyositis and Anti-EJ Autoantibody with Chronic Intestinal Pseudoobstruction Successfully Treated with Octreotide.

Authors:  Chiho Yamada; Shinji Sato; Noriko Sasaki; Takayoshi Kurabayashi; Sho Sasaki; Yasushi Koyama; Naofumi Chinen; Takayuki Wakabayashi; Yasuo Suzuki
Journal:  Case Rep Rheumatol       Date:  2016-11-03

3.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Isabel M McFarlane; Manjeet S Bhamra; Alexandra Kreps; Sadat Iqbal; Firas Al-Ani; Carla Saladini-Aponte; Christon Grant; Soberjot Singh; Khalid Awwal; Kristaq Koci; Yair Saperstein; Fray M Arroyo-Mercado; Derek B Laskar; Purna Atluri
Journal:  Rheumatology (Sunnyvale)       Date:  2018-03-30

Review 4.  Gastrointestinal Involvement in Systemic Sclerosis: An Update.

Authors:  John B Miller; Nisarg Gandhi; John Clarke; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2018-09       Impact factor: 3.517
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.